
Limited Clinical Benefit of Extracorporeal Shockwave Therapy for Insertional Achilles Tendinopathy

Limited Clinical Benefit of Extracorporeal Shockwave Therapy for Insertional Achilles Tendinopathy
Effectiveness of Extracorporeal Shockwave Therapy in the Treatment of Chronic Insertional Achilles Tendinopathy.
Foot Ankle Int . 2020 Apr;41(4):403-410Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Thirty-one patients with chronic insertional Achilles tendinopathy were randomized to receive low-energy extracorporeal shockwave therapy (ESWT) (n=16) or sham therapy (n=15). The primary outcome of interest was pain on a Visual Analogue Scale (VAS). The secondary outcome of interest was the VAS foot and ankle (VAS-FA) total score and pain, function and other complaints sub-scores. Additionally, t...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Join the Conversation
Please Login or Join to leave comments.